Filter
2645
Filtered Results: 2645
Text search:
regulatory
control
Featured
Recommendations
233
New Publications
716
Language
Document type
No document type
1288
Studies & Reports
468
Guidelines
460
Manuals
164
Strategic & Response Plan
144
Fact sheets
62
Situation Updates
23
Training Material
20
Resource Platforms
6
Brochures
5
Infographics
3
Online Courses
2
Countries / Regions
Global
109
Kenya
100
India
89
Ethiopia
60
Nigeria
54
Latin America and the Carribbean
49
Western and Central Europe
49
Uganda
46
Sierra Leone
45
South Africa
45
Liberia
43
Ghana
41
Africa
41
Zambia
36
Nepal
33
Tanzania
33
Bangladesh
31
Rwanda
28
Myanmar / Burma
28
Ukraine
27
Malawi
25
Namibia
24
South–East Asia Region
24
East and Southern Africa
23
West and Central Africa
23
Philippines
21
Syria
21
Eastern Europe
20
Lesotho
19
Middle East and North Africa
18
Paraguay
18
Guinea
13
Zimbabwe
13
Cambodia
12
Asia
12
Congo, Democratic Republic of
11
Mozambique
11
Botswana
11
El Salvador
11
Eastern Europe and Central Asia
11
Argentina
10
Eswatini/ Swaziland
10
South Sudan
9
Indonesia
9
Western Pacific Region
9
Russia
9
Senegal
8
Pakistan
7
Brazil
7
USA
6
Cameroon
6
Bolivia
6
Chile
6
Yemen
6
Burkina Faso
5
Haiti
5
Sudan
5
Colombia
5
Venezuela
5
Moldova
5
Spain
5
Somalia
4
Jordan
4
Germany
4
Thailand
4
Ecuador
4
Angola
4
Albania
4
Tajikistan
4
Georgia
4
Guinea-Bissau
3
Afghanistan
3
Chad
3
Benin
3
Peru
3
Laos
3
North America
3
United Kingdom
3
Mali
2
Saudi Arabia
2
Iraq
2
Lebanon
2
Papua New Guinea
2
Central African Republic
2
North Macedonia
2
Honduras
2
Guatemala
2
Madagascar
2
Bhutan
2
Timor Leste/ East Timor
2
Iran
2
Kazakhstan
2
Vietnam
2
Turkmenistan
2
Bosnia and Herzegovina
2
Côte d’Ivoire / Ivory Coast
1
Morocco
1
Niger
1
Turkey
1
Egypt
1
Gambia
1
Mauritania
1
Greece
1
Libya
1
Sri Lanka
1
Fiji
1
Palestine
1
Qatar
1
Uzbekistan
1
Kyrgyzstan
1
Australia
1
Gabon
1
Japan
1
Denmark
1
Maldives
1
Tunisia
1
Portugal
1
Belarus
1
Israel
1
Authors & Publishers
Publication Years
Category
Countries
1003
Clinical Guidelines
197
Public Health
183
Key Resources
122
Women & Child Health
92
Pharmacy & Technologies
66
Capacity Building
25
Toolboxes
COVID-19
274
AMR
176
HIV
164
TB
137
Pharmacy
120
Mental Health
118
Planetary Health
110
Rapid Response
100
Caregiver
90
NCDs
58
Ebola
54
NTDs
49
Global Health Education
45
Conflict
42
Specific Hazards
35
Disability
31
Refugee
28
Health Financing Toolbox
26
Natural Hazards
22
Zika
19
Polio
17
Cholera
9
Social Ethics
9
The goal of asthma treatment is to obtain clinical control and reduce future risks to the patient. To reach this goal in children with asthma, ongoing monitoring is essential. While all components of asthma, such as symptoms, lung function, bronchial hyperresponsiveness and inflammation, may exist i...
• provide scientific information on the safety, efficacy, and quality control/ quality assurance of widely used medicinal plants, in order to facilitate their appropriate use in Member States;
• provide models to assist Member States in developing their own mono- graphs or formularies for these...
• provide scientific information on the safety, efficacy, and quality control/ quality assurance of widely used medicinal plants, in order to facilitate their appropriate use in Member States;
• provide models to assist Member States in developing their own mono- graphs or formularies for these...
• provide scientific information on the safety, efficacy, and quality control/ quality assurance of widely used medicinal plants, in order to facilitate their appropriate use in Member States;
• provide models to assist Member States in developing their own mono- graphs or formularies for these...
The goal of the strategy is to prevent seasonal influenza, control the spread of influenza from animals to humans, and prepare for the next influenza pandemic.
The new strategy is the most comprehensive and far-reaching that WHO has ever developed for influenza. It outlines a path to protect popul...
This is the first NAP on the Prevention and Containment of AMR in Kenya. It has been developed based on the National Policy on Prevention and Containment of AMR and the recommendations of the situation analysis on AMR conducted in 2011 and updated in 2016. This strategy provides a regulatory and imp...
The document "Priority medical devices list for the COVID-19 response and associated technical specifications" complements this guideline.
This document provides interim guidance on the quality, performance characteristics and related standards of personal protective equipment (PPE) to be used i...
The development of this target product profile (TPP) was led by the WHO Department of Control of Neglected Tropical Diseases (NTD) following standard WHO guidance for TPP development. In order to identify and prioritize diagnostic needs, a WHO NTD Diagnostics Technical Advisory Group (DTAG) was form...
The development of this target product profile (TPP) was led by the WHO Department of Control of Ne-
glected Tropical Diseases (NTD) following standard WHO guidance for TPP development. In order to
identify and prioritize diagnostic needs, a WHO NTD Diagnostics Technical Advisory Group (DTAG)
was...
The occurrence of a high percentage of couterfeit medicines on the global medicines market is often attributed to a lack of effective regulation and a weak enforcement capacity. This review, while focusing on counterfeit medicines and medical devices in developing countries, will present information...
This new edition and fully updated publication replaces the 2012 UCG and is being circulated free of charge to all public and private sector prescribers, pharmacists, and regulatory authorities in the country
WHO Regional Publications, Western Pacific Series No. 23
Reports the findings and recommendations of a working group convened to prepare guidelines for the use of herbal medicines in Western Pacific countries. Addressed to national health authorities, the report responds to the widespread use o...
Reports the findings and recommendations of a working group convened to prepare guidelines for the use of herbal medicines in Western Pacific countries. Addressed to national health authorities, the report responds to the widespread use o...
These guidelines have been developed to provide guidance to the Ministry of Health in managing applications for registration of human pharmaceutical products in Rwanda. It was compiled by the Technical Working Group (TWG) on Medicines Evaluation and Registration (MER) of the East African Community M...
The current SEARVAP (South-East Asia regional vaccine action plan) describes a set of regional goals and objectives for immunization and control of vaccine-preventable diseases for 2016 – 2020 and highlights priority actions, targets and indicators that address the specific needs and challenges of...
Oral diseases are among the most common chronic diseases worldwide and constitute a major public health problem due to the huge health and economic burden on individuals, families, societies, and health care systems. The recent emphasis on the role of determinants of health, common risk factors and ...
Poor quality health services are holding back progress on improving health in countries at all income levels.
Today, inaccurate diagnosis, medication errors, inappropriate or unnecessary treatment, inadequate or unsafe clinical facilities or practices, or providers who lack adequate training an...
Today, inaccurate diagnosis, medication errors, inappropriate or unnecessary treatment, inadequate or unsafe clinical facilities or practices, or providers who lack adequate training an...
The strategic priorities of the CCS 2014–2018 are:
(1) Strengthening the health system.
(2) Enhancing the achievement of communicable disease control targets.
(3) Controlling the growth of the noncommunicable disease burden.
(4) Promoting health throughout the life course.
...
(1) Strengthening the health system.
(2) Enhancing the achievement of communicable disease control targets.
(3) Controlling the growth of the noncommunicable disease burden.
(4) Promoting health throughout the life course.
...
This document provides additional guidance for the responsible and prudent use of antimicrobials in food-producing animals, and should be read in conjunction with the Recommended International Code of Practice for Control of the Use of Veterinary Drugs CAC/RCP 38-1993. Its objectives are to minimize...
The document "Priority medical devices list for the COVID-19 response and associated technical specifications" complements this guideline.
This document provides interim guidance on the quality, performance characteristics and related standards of personal protective equipment (PPE) to be used i...
The meningitis road map has been designated as a flagship global strategy of the WHO’s Thirteenth General Programme of Work, 2019–2023 and is an essential component in achieving universal health coverage.
The road map will reinforce and combine with wider initiatives, such as those aimed at s...
